News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synbiotics (SBIO) Announces Distribution Agreement Wth Meridian Bioscience, Inc. (VIVO)


10/19/2005 5:13:03 PM

SAN DIEGO--(BUSINESS WIRE)--March 16, 2005--Synbiotics Corporation (Pink Sheets:SBIO) announced today that it has entered into a Distribution Agreement with Viral Antigens, Inc. (VAI), a wholly-owned subsidiary of Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) for the distribution of VAI's veterinary products through Synbiotics' global sales, marketing and distribution channels. Synbiotics currently develops, manufactures, and markets veterinary diagnostic products for the global animal health market and is seeking to broaden its product portfolio. Synbiotics will immediately begin marketing the Pseudorabies Virus Antibody test kit and the Autolex(R) Anti-PRV Screen globally. VAI will continue to supply PRV test kits directly to Japan. Pseudorabies Virus (PRV) is a contagious swine disease that causes reproductive problems, including abortion, stillbirths and even occasional death losses in breeding and finishing hogs. PRV has been one of the most costly of all swine diseases to the nation's pork producers. At its peak in the 1990's, the cost to pork producers alone was estimated to be $30 million annually represented in vaccination, testing, and animal loss costs. Over the past decade, a national control and eradication program for PRV was implemented to eliminate the presence of PRV in the swine population. Today, tight biosecurity, vaccination, testing, and good disease management practices are utilized to control the impact of PRV.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES